
Altitude Life Science Ventures
Description
Altitude Life Science Ventures (ALV) is a venture capital firm strategically located in Durango, Colorado, dedicated to investing in the burgeoning life science sector. The firm's core philosophy revolves around identifying and backing high-quality entrepreneurs within life science markets that demonstrate robust demand and significant growth potential. ALV primarily targets early-stage companies, focusing on innovations across various sub-sectors, including novel therapeutics, advanced diagnostics, cutting-edge medical devices, and other transformative life science technologies.
ALV positions itself as a key financial partner for its portfolio companies, often taking on the role of a lead investor or a significant co-investor in funding rounds. The firm typically engages with companies at the Seed to Series A stages of development, providing crucial capital during these foundational periods. Initial investments from Altitude Life Science Ventures generally range from $500,000 to $2 million, indicating their commitment to providing substantial early-stage funding to promising ventures. This targeted investment approach allows ALV to support companies through critical development milestones.
Established in 2004, Altitude Life Science Ventures has built a notable track record over nearly two decades in the life science investment landscape. Since its inception, the firm has actively invested in over 20 companies, demonstrating a consistent commitment to fostering innovation within the sector. Their experienced team, often comprising seasoned life science entrepreneurs and investors, leverages deep industry knowledge to identify and nurture companies poised for significant impact and growth. ALV's strategic focus on high-demand markets and strong entrepreneurial teams underpins its investment thesis, aiming to generate substantial returns while advancing critical scientific and medical breakthroughs.
Investor Profile
Altitude Life Science Ventures has backed more than 48 startups, with 1 new investments in the last 12 months alone. The firm has led 2 rounds, about 4% of its total and boasts 17 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Series C rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
- Typical check size: $500K – $2M.
Stage Focus
- Series B (33%)
- Series A (27%)
- Series C (23%)
- Series Unknown (6%)
- Series D (4%)
- Post Ipo Equity (4%)
- Seed (2%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Life Science
- Pharmaceutical
- Biopharma
- Genetics
- Nanotechnology
- Artificial Intelligence (Ai)
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.